The sold production of composite diagnostic or laboratory reagents in France is projected to decline from 317.93 million euros in 2024 to 304.81 million euros by 2028. If the standing value in 2023 was perceived to be consistent with the projected figures for 2024, the trend indicates a gradual reduction with a year-on-year decrease consistently observed through subsequent years. The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is negative, suggesting a downward trajectory over these years.

Future trends to watch for include:

Potential shifts in government policies or regulation that might impact production.
Technological advancements that could drive innovation and efficiency, potentially affecting production volumes.
Economic factors including inflation, currency fluctuations, and market demand shifts that may influence long-term forecasts.